KD PHARMA

Serial Number 98964888
641

Registration Progress

Application Filed
Jan 15, 2025
Under Examination
Approved for Publication
Published for Opposition
Registered

Basic Information

Serial Number
98964888
Deadline
September 24, 2025
Description
Respond to Non-Final Office Action
Filing Date
January 15, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
641
Status Date
Jun 24, 2025
Application
Pending
Classes
040

Rights Holder

K.D. Pharma Bexbach GmbH

99
Address
Am Kraftwerk 6
Bexbach 66450
DE

Ownership History

K.D. Pharma Bexbach GmbH

Original Applicant
99
Bexbach DE

Legal Representation

Attorney
Klaus P. Stoffel
USPTO Deadlines 2 active
Deadline Type Event Code Deadline Date Days Until Priority Extension Available
OFFICE ACTION
Non-Final Action Mailed
CNRTR Sep 24, 2025 79 days Critical Until Dec 24, 2025
OFFICE ACTION
Non-Final Action E-Mailed
GNRTF Sep 24, 2025 79 days Critical Until Dec 24, 2025
Next deadline: Non-Final Action Mailed on September 24, 2025 (79 days)

Application History

6 events
Date Code Type Description
Jun 24, 2025 GNRT F NON-FINAL ACTION E-MAILED
Jun 24, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 24, 2025 CNRT R NON-FINAL ACTION WRITTEN
Jun 24, 2025 DOCK D ASSIGNED TO EXAMINER
Jun 15, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 15, 2025 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 040
Custom manufacture of pharmaceuticals, medical and veterinary preparations, sanitary preparations for medical purposes, dietetic foodstuffs and products for medical or veterinary purposes, food supplements for humans and animals, disinfectants, medicines and natural remedies, dietetic preparations and food supplements and pharmaceutical preparations and substances, dietary supplements and dietetic preparations, food for babies and infants, beverages for infants and infant formula; Custom manufacture of oils and fats, dietary oils and fats, edible oils and fats, oils and fats for the production of edible oils and fats; Custom manufacture of pharmaceutical, food and dietary supplements and pharmaceutical preparations and substances for medical purposes with omega-3 extracts contained therein in the form of oils, fats, powders or capsules for third parties; none of the foregoing featuring or providing cannabis or cannabis derived ingredients with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; none of the foregoing services featuring or providing cannabidiol (CBD)

Active Deadlines

Non-Final Action Mailed
Due: Sep 24, 2025
Non-Final Action E-Mailed
Due: Sep 24, 2025

Classification

International Classes
040